论文部分内容阅读
在癌症病人的分期和随访中,用放射性核素(radionuclide)扫描来发现有无转移,虽已占重要地位,而在妇科肿瘤中却报导不多.作者对28例子宫癌,33例子富颈癌及40例卵巢癌在最初分期中作了肝与骨的扫描以发现阳性率.54例作了骨扫描,101例做了肝扫描.全身骨扫描是在注入20mCi 99mTc-methylene diphosphonate(MDP)后2～4小时完成,每个显像积分数300,000;肝扫描是在注入3mCi 99mTc-Sulfur colloid后完成,显像积分数400,000.扫描医师不了解病变的临床期别.骨扫描时如见到典型的骨退行性病变,关节侵犯或明显骨折,则为(一).肝扫描时如见到肝内局限性缺损,提示有明
In the staging and follow-up of cancer patients, radionuclide scanning was used to detect metastasis. Although it has occupied an important position, it has not been reported in gynecologic tumors. The author of 28 cases of uterine cancer, 33 examples of neck Carcinoma and 40 cases of ovarian cancer were examined during the initial stages of liver and bone scan to find the positive rate. 54 bone scans were performed and 101 liver scans were performed. Whole body bone scan was performed with 20mCi 99mTc-methylene diphosphonate (MDP) injected. After 2 to 4 hours, the number of imaging points was 300,000; the liver scan was performed after injecting 3mCi of 99mTc-Sulfur colloid, and the number of imaging points was 400,000. The scan doctor did not understand the clinical stage of the lesion. Seen during bone scan Typical bone degenerative lesions, joint invasion or obvious fractures are (1). If liver lesions are seen during hepatic scan, it is obvious that